From: Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
Location
Treatment group
NAC (n = 18)
NACRT (n = 16)
Overall relapse (present), n (%)
1 (5%)
5 (31%)
Local relapse (present), n (%)
2 (13%)
Distal relapse (pulmonary and liver), n (%)
0
3 (19%)